Literature DB >> 8408566

Detection of Trypanosoma cruzi in blood specimens of chronic chagasic patients by polymerase chain reaction amplification of kinetoplast minicircle DNA: comparison with serology and xenodiagnosis.

H A Avila1, J B Pereira, O Thiemann, E De Paiva, W DeGrave, C M Morel, L Simpson.   

Abstract

A panel of 114 blood samples from chronic chagasic patients and nonchagasic patients was screened for Trypanosoma cruzi by xenodiagnostic, serologic, and polymerase chain reaction (PCR) amplification tests. Blood samples were preserved in a guanidine-EDTA buffer, and total blood DNA was isolated after chemical nuclease cleavage with 1,10-phenanthroline-copper ion and used as a template for PCR amplification of the conserved and variable regions of T. cruzi minicircle molecules. The PCR products were screened by Southern blot hybridization with a digoxigenin-labeled oligonucleotide probe specific for the conserved region of the minicircle. The method showed a sensitivity of 100% compared with the serologic test. In addition, all of the serology-positive, xenodiagnosis-negative samples were positive by PCR. This demonstrates that PCR amplification of T. cruzi kinetoplast minicircle DNA could replace xenodiagnosis for evaluation of parasitemia in chronic chagasic patients and could serve as a complement for serologic testing in the screening of blood bank donors.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8408566      PMCID: PMC265772          DOI: 10.1128/jcm.31.9.2421-2426.1993

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  17 in total

Review 1.  Trypanosoma cruzi, the etiologic agent of Chagas' disease: status in the blood supply in endemic and nonendemic countries.

Authors:  G A Schmuñis
Journal:  Transfusion       Date:  1991 Jul-Aug       Impact factor: 3.157

2.  A clonal theory of parasitic protozoa: the population structures of Entamoeba, Giardia, Leishmania, Naegleria, Plasmodium, Trichomonas, and Trypanosoma and their medical and taxonomical consequences.

Authors:  M Tibayrenc; F Kjellberg; F J Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  1990-04       Impact factor: 11.205

3.  Establishment of PCR for the early diagnosis of herpes simplex encephalitis.

Authors:  E Puchhammer-Stöckl; T Popow-Kraupp; F X Heinz; C W Mandl; C Kunz
Journal:  J Med Virol       Date:  1990-10       Impact factor: 2.327

4.  Schizodeme analysis of Trypanosoma cruzi stocks from South and Central America by analysis of PCR-amplified minicircle variable region sequences.

Authors:  H Avila; A M Goncalves; N S Nehme; C M Morel; L Simpson
Journal:  Mol Biochem Parasitol       Date:  1990 Sep-Oct       Impact factor: 1.759

5.  Sensitive detection and schizodeme classification of Trypanosoma cruzi cells by amplification of kinetoplast minicircle DNA sequences: use in diagnosis of Chagas' disease.

Authors:  N R Sturm; W Degrave; C Morel; L Simpson
Journal:  Mol Biochem Parasitol       Date:  1989-03-15       Impact factor: 1.759

6.  Strains and clones of Trypanosoma cruzi can be characterized by pattern of restriction endonuclease products of kinetoplast DNA minicircles.

Authors:  C Morel; E Chiari; E P Camargo; D M Mattei; A J Romanha; L Simpson
Journal:  Proc Natl Acad Sci U S A       Date:  1980-11       Impact factor: 11.205

7.  Natural populations of Trypanosoma cruzi, the agent of Chagas disease, have a complex multiclonal structure.

Authors:  M Tibayrenc; P Ward; A Moya; F J Ayala
Journal:  Proc Natl Acad Sci U S A       Date:  1986-01       Impact factor: 11.205

8.  Peculiar sequence organization of kinetoplast DNA minicircles from Trypanosoma cruzi.

Authors:  W Degrave; S P Fragoso; C Britto; H van Heuverswyn; G Z Kidane; M A Cardoso; R U Mueller; L Simpson; C M Morel
Journal:  Mol Biochem Parasitol       Date:  1988-01-01       Impact factor: 1.759

9.  Use of a questionnaire to identify potential blood donors at risk for infection with Trypanosoma cruzi.

Authors:  M D Appleman; I A Shulman; S Saxena; L V Kirchhoff
Journal:  Transfusion       Date:  1993-01       Impact factor: 3.157

10.  Radiolabeled total parasite DNA probe specifically detects Trypanosoma cruzi in mammalian blood.

Authors:  F Ashall; D A Yip-Chuck; A A Luquetti; M A Miles
Journal:  J Clin Microbiol       Date:  1988-03       Impact factor: 5.948

View more
  33 in total

1.  trans-sialidase inhibition assay, a highly sensitive and specific diagnostic test for Chagas' disease.

Authors:  A S Buchovsky; O Campetella; G Russomando; L Franco; R Oddone; N Candia; A Luquetti; S M Gonzalez Cappa; M S Leguizamon
Journal:  Clin Diagn Lab Immunol       Date:  2001-01

2.  Infectivity for mice of Trypanosoma cruzi I and II strains isolated from different hosts.

Authors:  Marta Bértoli; Miriam Hitomi Andó; Max Jean De Ornelas Toledo; Silvana Marques De Araújo; Mônica Lúcia Gomes
Journal:  Parasitol Res       Date:  2006-01-31       Impact factor: 2.289

3.  Evidence of Trypanosoma cruzi II infection in Colombian chagasic patients.

Authors:  German Zafra; Julio Cesar Mantilla; Helder Magno Valadares; Andrea Mara Macedo; Clara Isabel González
Journal:  Parasitol Res       Date:  2008-06-04       Impact factor: 2.289

Review 4.  Kinetoplastids: related protozoan pathogens, different diseases.

Authors:  Ken Stuart; Reto Brun; Simon Croft; Alan Fairlamb; Ricardo E Gürtler; Jim McKerrow; Steve Reed; Rick Tarleton
Journal:  J Clin Invest       Date:  2008-04       Impact factor: 14.808

5.  Comparison of PCR and microscopic methods for detecting Trypanosoma cruzi.

Authors:  L V Kirchhoff; J R Votava; D E Ochs; D R Moser
Journal:  J Clin Microbiol       Date:  1996-05       Impact factor: 5.948

6.  Detection of Trypanosoma cruzi and T. rangeli infections from Rhodnius pallescens bugs by loop-mediated isothermal amplification (LAMP).

Authors:  Oriel M M Thekisoe; Carol V Rodriguez; Francisco Rivas; Andrea M Coronel-Servian; Shinya Fukumoto; Chihiro Sugimoto; Shin-Ichiro Kawazu; Noboru Inoue
Journal:  Am J Trop Med Hyg       Date:  2010-05       Impact factor: 2.345

7.  Posttherapeutic cure criteria in Chagas' disease: conventional serology followed by supplementary serological, parasitological, and molecular tests.

Authors:  G F Machado-de-Assis; A R Silva; V A L Do Bem; M T Bahia; O A Martins-Filho; J C P Dias; P Albajar-Viñas; R M Torres; M Lana
Journal:  Clin Vaccine Immunol       Date:  2012-06-27

8.  Risk progression to chronic Chagas cardiomyopathy: influence of male sex and of parasitaemia detected by polymerase chain reaction.

Authors:  A L Basquiera; A Sembaj; A M Aguerri; M Omelianiuk; S Guzmán; J Moreno Barral; T F Caeiro; R J Madoery; O A Salomone
Journal:  Heart       Date:  2003-10       Impact factor: 5.994

Review 9.  DNA probes and PCR for diagnosis of parasitic infections.

Authors:  J B Weiss
Journal:  Clin Microbiol Rev       Date:  1995-01       Impact factor: 26.132

10.  Chagas cardiomyopathy in the context of the chronic disease transition.

Authors:  Alicia I Hidron; Robert H Gilman; Juan Justiniano; Anna J Blackstock; Carlos Lafuente; Walter Selum; Martiza Calderon; Manuela Verastegui; Lisbeth Ferrufino; Eduardo Valencia; Jeffrey A Tornheim; Seth O'Neal; Robert Comer; Gerson Galdos-Cardenas; Caryn Bern
Journal:  PLoS Negl Trop Dis       Date:  2010-05-18
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.